Bionik Laboratories (BNKL) Stock Price, News & Analysis

Company Overview

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 6,000 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BNKL Stock Analysis - Frequently Asked Questions

How do I buy shares of Bionik Laboratories?

Shares of BNKL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Bionik Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Bionik Laboratories investors own include Ashford Hospitality Trust (AHT), Assertio (ASRT), Peabody Energy (BTU), Co-Diagnostics (CODX), Adamis Pharmaceuticals (ADMP), PlayAGS (AGS) and Ardmore Shipping (ASC).

Company Calendar

• Today: 2/01/2025
• Fiscal Year End: 3/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical appliances & supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:BNKL
• CUSIP: N/A
• CIK: 1508381
• Web: www.bioniklabs.com
• Phone: (617) 926-4800
• Fax: N/A
• Employees: 12
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $1.80 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.24) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 12,480,000
• Free Float: 8,148,000
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: -1.30